Literature DB >> 24293391

HIF-1α P582S and A588T polymorphisms and digestive system cancer risk-a meta-analysis.

Xi Yang1, Chi Zhang, Hong-Cheng Zhu, Qin Qin, Lian-Jun Zhao, Jia Liu, Li-Ping Xu, Qu Zhang, Jing Cai, Jian-Xin Ma, Hong-Yan Cheng, Xin-Chen Sun.   

Abstract

Hypoxia-inducible factor-1 (HIF-1) influences cancer progression and metastasis through various mechanisms, and HIF-1α polymorphisms are reportedly associated with many cancers; however, the associations of HIF-1α P582S and A588T polymorphisms with the risk of digestive system cancer remain inconclusive. To understand the role of HIF-1α P582S and A588T genotypes in digestive cancer development, we conducted a comprehensive meta-analysis involving 1,517 cases and 3,740 controls. Overall, the P582S polymorphism was not significantly associated with digestive system cancers in all genotypes. By contrast, the A588T polymorphism was significantly associated with digestive system cancers in the dominant model (TT/AT vs. AA: OR = 3.17, 95% CI: 1.21, 8.25; P heterogeneity < 0.001). In subgroup analysis for cancer types, the two polymorphisms were only associated with increased risk of pancreatic cancer (P582S: SS vs. PP: OR = 2.51, 95% CI: 1.31, 4.81; SS vs. PP/PS: OR = 8.73, 95% CI: 1.33, 57.1; A588T: TT vs. AA: OR = 9.30, 95% CI: 1.12, 77.6; P heterogeneity = 0.478; TT vs. AA/AT: OR = 3.14, 95% CI: 1.99, 4.97; P heterogeneity = 0.098; TT/AT vs. AA: OR = 8.65, 95% CI: 1.05, 71.6; P heterogeneity = 0.418). According to the source of ethnicity, the P582S and the A588T polymorphisms are both significantly associated with an increased risk of cancer among Caucasians in the homozygote model (SS vs. PP: OR = 2.41, 95% CI: 1.24, 4.691; P heterogeneity = 0.010; TT vs. AA: OR = 98.6, 95% CI: 4.37, 2,224; P heterogeneity = 0.040) and the recessive model (SS vs. PP/PS: OR = 9.48, 95% CI: 1.12, 80.3; P heterogeneity < 0.001; TT vs. AA/AT: OR = 82.7, 95% CI: 3.79, 1,802; P heterogeneity = 0.041). Our findings suggest that the HIF-1α A588T polymorphism is significantly associated with higher cancer risk and the P582S polymorphism is significantly associated with pancreatic cancer risk. Furthermore, the effect of both polymorphisms on digestive system cancer is more pronounced among Caucasians than that among Asians.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24293391     DOI: 10.1007/s13277-013-1375-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

1.  Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer.

Authors:  Bernd Frank; Michael Hoffmeister; Norman Klopp; Thomas Illig; Jenny Chang-Claude; Hermann Brenner
Journal:  Carcinogenesis       Date:  2010-04-19       Impact factor: 4.944

2.  1790 G/A polymorphism, but not 1772 C/T polymorphism, is significantly associated with cancers: an update study.

Authors:  Jie Liu; Hong-Xin Zhang
Journal:  Gene       Date:  2013-04-10       Impact factor: 3.688

3.  Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer.

Authors:  Min-Jung Kang; Sung-Ae Jung; Ji Min Jung; Seong-Eun Kim; Hye-Kyung Jung; Tae-Hun Kim; Ki-Nam Shim; Sun Young Yi; Kwon Yoo; Il Hwan Moon
Journal:  Anticancer Res       Date:  2011-02       Impact factor: 2.480

4.  Common single nucleotide polymorphism of hypoxia-inducible factor-1alpha and its impact on the clinicopathological features of esophageal squamous cell carcinoma.

Authors:  Ting Sheng Ling; Rui Hua Shi; Guo Xin Zhang; Hong Zhu; Lian Zhen Yu; Xia Feng Ding
Journal:  Chin J Dig Dis       Date:  2005

5.  Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis.

Authors:  Joanna Szkandera; Gudrun Knechtel; Michael Stotz; Günter Hofmann; Uwe Langsenlehner; Peter Krippl; Tanja Langsenlehner; Dadbeh Dehchamani; Hellmut Samonigg; Wilfried Renner; Armin Gerger
Journal:  Anticancer Res       Date:  2010-06       Impact factor: 2.480

6.  Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma.

Authors:  Toshio Kuwai; Yasuhiko Kitadai; Shinji Tanaka; Tsuyoshi Kuroda; Takehiko Ochiumi; Shunji Matsumura; Naohide Oue; Wataru Yasui; Mika Kaneyasu; Keiji Tanimoto; Masahiko Nishiyama; Kazuaki Chayama
Journal:  Oncol Rep       Date:  2004-11       Impact factor: 3.906

7.  Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance.

Authors:  Keiji Tanimoto; Koji Yoshiga; Hidetaka Eguchi; Mika Kaneyasu; Kei Ukon; Tsutomu Kumazaki; Naohide Oue; Wataru Yasui; Kazue Imai; Kei Nakachi; Lorenz Poellinger; Masahiko Nishiyama
Journal:  Carcinogenesis       Date:  2003-08-14       Impact factor: 4.944

8.  Association of the hypoxia inducible factor-1alpha gene polymorphisms with gastric cancer in Tibetans.

Authors:  Kang Li; Yali Zhang; Zeng Dan; Yi Wang; Zhuoma Ci Ren
Journal:  Biochem Genet       Date:  2009-06-07       Impact factor: 1.890

9.  Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer.

Authors:  Jaime Ruiz-Tovar; Maria Encarnación Fernandez-Contreras; Elena Martín-Perez; Carlos Gamallo
Journal:  Tumori       Date:  2012 May-Jun

Review 10.  Hypoxia-regulated target genes implicated in tumor metastasis.

Authors:  Ya-Ping Tsai; Kou-Juey Wu
Journal:  J Biomed Sci       Date:  2012-12-14       Impact factor: 8.410

View more
  4 in total

1.  Genetic variants and risk of esophageal squamous cell carcinoma: a GWAS-based pathway analysis.

Authors:  Xi Yang; Hongcheng Zhu; Qin Qin; Yuehua Yang; Yan Yang; Hongyan Cheng; Xinchen Sun
Journal:  Gene       Date:  2014-11-26       Impact factor: 3.688

2.  TCN, an AKT inhibitor, exhibits potent antitumor activity and enhances radiosensitivity in hypoxic esophageal squamous cell carcinoma in vitro and in vivo.

Authors:  Qing Guo; Jia He; Feng Shen; Wei Zhang; Xi Yang; Chi Zhang; Qu Zhang; Jun-Xing Huang; Zheng-Dong Wu; Xin-Chen Sun; Sheng-Bin Dai
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

Review 3.  HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies.

Authors:  I Gladek; J Ferdin; S Horvat; G A Calin; T Kunej
Journal:  Genes Chromosomes Cancer       Date:  2017-03-31       Impact factor: 5.006

4.  Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1α.

Authors:  Xi Yang; Hongcheng Zhu; Yangyang Ge; Jia Liu; Jing Cai; Qin Qin; Liangliang Zhan; Chi Zhang; Liping Xu; Zheming Liu; Yan Yang; Yuehua Yang; Jianxin Ma; Hongyan Cheng; Xinchen Sun
Journal:  Tumour Biol       Date:  2014-07-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.